These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28445233)

  • 21. Patient-derived xenograft models of breast cancer and their predictive power.
    Whittle JR; Lewis MT; Lindeman GJ; Visvader JE
    Breast Cancer Res; 2015 Feb; 17(1):17. PubMed ID: 25849559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Of mice and humans: are they the same?--Implications in cancer translational research.
    de Jong M; Maina T
    J Nucl Med; 2010 Apr; 51(4):501-4. PubMed ID: 20237033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a novel radiation-induced sarcoma cell line.
    Lang J; Zhu W; Nokes B; Sheth G; Novak P; Fuchs L; Watts G; Futscher B; Mineyev N; Ring A; LeBeau L; Nagle R; Cranmer L
    J Surg Oncol; 2015 May; 111(6):669-82. PubMed ID: 25644184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
    Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
    Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IT Infrastructure of an Oncological Trial Where Xenografts Inform Individual Second Line Treatment Decision.
    Lindoerfer D; Mansmann U
    Stud Health Technol Inform; 2017; 235():226-230. PubMed ID: 28423787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma.
    Garg V; Zhang W; Gidwani P; Kim M; Kolb EA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5446-54. PubMed ID: 17875774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
    Nanni P; Nicoletti G; Landuzzi L; Croci S; Murgo A; Palladini A; Antognoli A; Ianzano ML; Stivani V; Grosso V; Maira SM; García-Echeverría C; Scotlandi K; De Giovanni C; Lollini PL
    Eur J Cancer; 2010 Feb; 46(3):659-68. PubMed ID: 20031388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically Engineered Mouse Models for Liver Cancer.
    Cho K; Ro SW; Seo SH; Jeon Y; Moon H; Kim DY; Kim SU
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond genomics: critical evaluation of cell line utility for ovarian cancer research.
    Elias KM; Emori MM; Papp E; MacDuffie E; Konecny GE; Velculescu VE; Drapkin R
    Gynecol Oncol; 2015 Oct; 139(1):97-103. PubMed ID: 26321251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-Derived Xenografts as a Model System for Radiation Research.
    Willey CD; Gilbert AN; Anderson JC; Gillespie GY
    Semin Radiat Oncol; 2015 Oct; 25(4):273-80. PubMed ID: 26384275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer.
    Hammer S; Sommer A; Fichtner I; Becker M; Rolff J; Merk J; Klar U; Hoffmann J
    Clin Cancer Res; 2010 Mar; 16(5):1452-65. PubMed ID: 20179216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations.
    Kresse SH; Meza-Zepeda LA; Machado I; Llombart-Bosch A; Myklebost O
    Cancer; 2012 Jan; 118(2):558-70. PubMed ID: 21713766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of publicly available sarcoma cell lines for use in proteomic studies.
    Pan X; Yoshida A; Kawai A; Kondo T
    Expert Rev Proteomics; 2016; 13(2):227-40. PubMed ID: 26653594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis.
    Jordan S; Chung J; Distler O
    Curr Opin Rheumatol; 2013 Nov; 25(6):679-85. PubMed ID: 24047603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management and potentialities of primary cancer cultures in preclinical and translational studies.
    Miserocchi G; Mercatali L; Liverani C; De Vita A; Spadazzi C; Pieri F; Bongiovanni A; Recine F; Amadori D; Ibrahim T
    J Transl Med; 2017 Nov; 15(1):229. PubMed ID: 29116016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer models for novel drug discovery.
    Golovko D; Kedrin D; Yilmaz ÖH; Roper J
    Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetically engineered models have advantages over xenografts for preclinical studies.
    Becher OJ; Holland EC
    Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug safety testing paradigm, current progress and future challenges: an overview.
    Ahuja V; Sharma S
    J Appl Toxicol; 2014 Jun; 34(6):576-94. PubMed ID: 24777877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.
    Wang W; Iyer NG; Tay HT; Wu Y; Lim TK; Zheng L; Song IC; Kwoh CK; Huynh H; Tan PO; Chow PK
    BMC Cancer; 2015 Oct; 15():828. PubMed ID: 26520397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.